DR

Devi Reeta

Active Director Director DIN 10056698
DIN 10056698 First appointment Feb 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Devi Reeta

Data last updated:

Devi Reeta is a Director at Avecure Biosciences Private Limited (since 2023). The company operates in Pharma. Avecure Biosciences Private Limited reported revenue of ₹65.6 Lakh (FY 2023).

DIN 10056698
Primary Designation Director
Industry Pharma
First Appointment 27 Feb 2023
Oldest Company Age 5 yrs
Largest company Avecure Biosciences Private Limited · ₹65.6 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avecure Biosciences Private Limited U24239DL2021PTC376244
Director27 Feb 20232021₹65.6 Lakh (FY 2023)Active

Board colleagues of Devi Reeta

NameDINCompanyDesignation
Jay Prakash08844780Avecure Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avecure Biosciences Private Limited
Premium access

Shareholding and investment profile for Devi Reeta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devi Reeta

Devi Reeta currently holds 1 directorship: Avecure Biosciences Private Limited (Director, since 27 Feb 2023, revenue ₹65.6 Lakh (FY 2023)).

Devi Reeta was first appointed on 27 Feb 2023 as Director at Avecure Biosciences Private Limited.

The current boards of Devi Reeta's companies include Jay Prakash (Avecure Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available